Skip to main content
OpenTrials

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

3,328 public trials 611 recruiting studies
Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

NCT01076452

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • VA Medical Center, San Francisco San Francisco, California, United States
  • VA Greater Los Angeles Healthcare System, West LA West Los Angeles, California, United States
View all 14 locations
View Trial Details
Completed

Pivotal Study in Advanced Parkinsons Disease Patients

NCT00466167

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.525.43005 Boehringer Ingelheim Investigational Site Linz, Austria
  • 248.525.42003 Boehringer Ingelheim Investigational Site Pardubice, Czechia
  • 248.525.42001 Boehringer Ingelheim Investigational Site Prague, Czechia
  • 248.525.42005 Boehringer Ingelheim Investigational Site Rakovník, Czechia
View all 76 locations
View Trial Details
Completed

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Boehringer Ingelheim Investigational Site 1 Bad Ischl, Austria
  • Boehringer Ingelheim Investigational Site 2 Bad Radkersburg, Austria
  • Boehringer Ingelheim Investigational Site 3 Baden, Austria
  • Boehringer Ingelheim Investigational Site 4 Baden, Austria
View all 284 locations
View Trial Details
Completed

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778

Conditions
Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +9 more
Locations
  • 248.596.43003 Boehringer Ingelheim Investigational Site Graz, Austria
  • 248.596.43001 Boehringer Ingelheim Investigational Site Innsbruck, Austria
  • 248.596.43005 Boehringer Ingelheim Investigational Site Linz, Austria
  • 248.596.43004 Boehringer Ingelheim Investigational Site Sankt Pölten, Austria
View all 77 locations
View Trial Details
Completed

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.633.01004 Boehringer Ingelheim Investigational Site Sun City, Arizona, United States
  • 248.633.01018 Boehringer Ingelheim Investigational Site Tempe, Arizona, United States
  • 248.633.01016 Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • 248.633.01013 Boehringer Ingelheim Investigational Site Oxnard, California, United States
View all 119 locations
View Trial Details
Completed

Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

NCT00613301

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Boehringer Ingelheim Investigational Site 11 Akita, Japan
  • Boehringer Ingelheim Investigational Site 95 Anan, Japan
  • Boehringer Ingelheim Investigational Site 1 Asahikawa, Japan
  • Boehringer Ingelheim Investigational Site 2 Asahikawa, Japan
View all 119 locations
View Trial Details

Related conditions